To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

No analgesic advantage of liposomal bupivacaine over ropivacaine for infiltration analgesia in TKA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2018

No analgesic advantage of liposomal bupivacaine over ropivacaine for infiltration analgesia in TKA

Vol: 7| Issue: 10| Number:22| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A

Periarticular Ropivacaine Cocktail Is Equivalent to Liposomal Bupivacaine Cocktail in Bilateral Total Knee Arthroplasty

J Arthroplasty. 2018 Aug;33(8):2455-2459. doi: 10.1016/j.arth.2018.02.083

Contributing Authors:
PF Sharkey JR Danoff R Goel RA Henderson J Fraser

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

29 patients scheduled bilateral knee arthroplasty were randomized to intervention in one knee with liposomal bupivacaine periarticular infiltration analgesia and in the other knee with ropivacaine periarticular infiltration analgesia. Patients were assessed over the first two postoperative days for pain, subjective function, and incidence of complications. No significant differences between groups...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue